Cargando…

Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling

Adiponectin and the other 15 members of the complement 1q (C1q)/tumor necrosis factor (TNF)-related protein (CTRP) family are secreted proteins composed of an N-terminal variable domain followed by a stalk region and a characteristic C-terminal trimerizing globular C1q (gC1q) domain originally ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schanbacher, Constanze, Hermanns, Heike M., Lorenz, Kristina, Wajant, Harald, Lang, Isabell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952994/ https://www.ncbi.nlm.nih.gov/pubmed/36831095 http://dx.doi.org/10.3390/biomedicines11020559

Ejemplares similares

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
por: Lang, Isabell, et al.
Publicado: (2018)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
por: Zaitseva, Olena, et al.
Publicado: (2023)

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
por: Kucka, Kirstin, et al.
Publicado: (2021)

Membrane lymphotoxin-α(2)β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist
por: Kucka, Kirstin, et al.
Publicado: (2021)

Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
por: Medler, Juliane, et al.
Publicado: (2022)

Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
por: Wajant, Harald, et al.
Publicado: (2019)

Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells
por: Ticha, Olga, et al.
Publicado: (2018)

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies
por: Lang, Isabell, et al.
Publicado: (2022)

Lonicerae Japonicae Flos extract and chlorogenic acid attenuates high-fat-diet- induced prediabetes via CTRPs-AdipoRs-AMPK/PPARα axes
por: Guo, Chengcheng, et al.
Publicado: (2022)

Tumor Necrosis Factor Induces Tumor Promoting and Anti-Tumoral Effects on Pancreatic Cancer via TNFR1
por: Chopra, Martin, et al.
Publicado: (2013)

C1q Complement/Tumor Necrosis Factor-Associated Proteins in Cardiovascular Disease and COVID-19
por: Xie, Yaoli, et al.
Publicado: (2021)

TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
por: Carmona Arana, José Antonio, et al.
Publicado: (2014)

TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer
por: Siegmund, Daniela, et al.
Publicado: (2022)

Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling
por: Füllsack, Simone, et al.
Publicado: (2019)

RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer
por: Thanasupawat, Thatchawan, et al.
Publicado: (2015)

Tumor necrosis factor receptor family costimulation increases regulatory T‐cell activation and function via NF‐κB
por: Lubrano di Ricco, Martina, et al.
Publicado: (2020)

Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
por: Wajant, Harald
Publicado: (2019)

Plasma Complement C1q/tumor necrosis factor-related protein 15 concentration is associated with polycystic ovary syndrome
por: Vatannejad, Akram, et al.
Publicado: (2022)

TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling
por: Kreckel, Jennifer, et al.
Publicado: (2019)

Tumor necrosis factor receptor-mediated signaling pathways
Publicado: (1994)

ERK1/2 Activity Is Critical for the Outcome of Ischemic Stroke
por: Schanbacher, Constanze, et al.
Publicado: (2022)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Mukaro, Violet R., et al.
Publicado: (2018)

RNPS1 inhibits excessive tumor necrosis factor/tumor necrosis factor receptor signaling to support hematopoiesis in mice
por: Zhong, Xue, et al.
Publicado: (2022)

Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5)
Publicado: (1988)

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2023)

Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors
por: Sirtl, Simon, et al.
Publicado: (2018)

Circulating complement‐1q tumor necrosis factor‐α‐related protein isoform 5 levels are low in type 2 diabetes patients and reduced by dapagliflozin
por: Zhang, Cheng, et al.
Publicado: (2019)

Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1
por: Lee, Ji-Hyun, et al.
Publicado: (2018)

Bispecific soluble cytokine receptor-nanobody fusions inhibit Interleukin (IL-)6 trans-signaling and IL-12/23 or tumor necrosis factor (TNF) signaling
por: Gesiorowski, Annika, et al.
Publicado: (2023)

Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
por: Gough, Portia, et al.
Publicado: (2020)

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
por: Hokstad, Ingrid, et al.
Publicado: (2019)

TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2018)

Complementation of Lymphotoxin α Knockout Mice with Tumor Necrosis Factor–expressing Transgenes Rectifies Defective Splenic Structure and Function
por: Alexopoulou, Lena, et al.
Publicado: (1998)

Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy
por: Zaitseva, Olena, et al.
Publicado: (2022)

Structural insights of homotypic interaction domains in the ligand-receptor signal transduction of tumor necrosis factor (TNF)
por: Park, Young-Hoon, et al.
Publicado: (2016)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

Structural biology of complement receptors
por: Santos-López, Jorge, et al.
Publicado: (2023)

Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling
por: Williams, Anwen, et al.
Publicado: (2016)

Principles of antibody-mediated TNF receptor activation
por: Wajant, H
Publicado: (2015)

Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling
por: Cope, Andrew P., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_d59425c0qpg16iguin12dc3e29